Skip to content

Author

Saroj Verma

We have 1 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Non-β-lactam inhibitors targeting KPC-2 β-lactamase: Structural insights and rational design strategies to combat antimicrobial drug resistance.

The rational design, mechanisms of action, and structure-activity relationships (SAR) of non-β-lactam KPC-2 β-lactamase inhibitors, including diazabicyclooctanes (DBOs), boronic acid (BA)-based inhibitors, and emerging scaffolds are discussed to provide insights into the rational design of next-generation, potent BLIs.

Mustafa Hassan Ibrahim Kashkosh, Saroj Verma · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.